Merrithew & Thorsten’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-106
Closed -$22K – 24
2026
Q2
$22K Hold
106
– – 0.02% 62
2026
Q1
$19K Hold
106
– – 0.02% 63
2025
Q4
$18K Buy
+106
New +$17.3K 0.02% 64

Other funds holding BIIB

Merrithew & Thorsten's BIIB Position: Q3 2026 in Review

Merrithew & Thorsten sold out of Biogen (BIIB) in Q3 2026, closing a stake of 106 shares — an estimated $22K sold.

Merrithew & Thorsten first reported a position in BIIB in Q4 2025 and held it in 3 quarters. The position peaked at $22K in Q2 2026. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Merrithew & Thorsten reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
  • Merrithew & Thorsten sold 106 Biogen shares in Q3 2026, an estimated $22K.
  • Merrithew & Thorsten first reported a position in Biogen in Q4 2025 and held it in 3 quarters.
  • Merrithew & Thorsten's Biogen position peaked at $22K in Q2 2026.
  • 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Merrithew & Thorsten's 13F filing for Q3 2026, filed 6 Nov 2026.